Found 4 hits for monomerid = 202487 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM202487
(US9539260, A1 | US9763952, Example A1)Show SMILES COc1ncc(cc1C)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOCC3)cc12 |r| Show InChI InChI=1S/C25H31N3O5/c1-17-13-19(15-26-24(17)30-2)28-9-12-32-23-4-3-20(14-22(23)28)33-21-5-8-27(16-21)25(29)18-6-10-31-11-7-18/h3-4,13-15,18,21H,5-12,16H2,1-2H3/t21-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 322 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM202487
(US9539260, A1 | US9763952, Example A1)Show SMILES COc1ncc(cc1C)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOCC3)cc12 |r| Show InChI InChI=1S/C25H31N3O5/c1-17-13-19(15-26-24(17)30-2)28-9-12-32-23-4-3-20(14-22(23)28)33-21-5-8-27(16-21)25(29)18-6-10-31-11-7-18/h3-4,13-15,18,21H,5-12,16H2,1-2H3/t21-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM202487
(US9539260, A1 | US9763952, Example A1)Show SMILES COc1ncc(cc1C)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOCC3)cc12 |r| Show InChI InChI=1S/C25H31N3O5/c1-17-13-19(15-26-24(17)30-2)28-9-12-32-23-4-3-20(14-22(23)28)33-21-5-8-27(16-21)25(29)18-6-10-31-11-7-18/h3-4,13-15,18,21H,5-12,16H2,1-2H3/t21-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 322 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM202487
(US9539260, A1 | US9763952, Example A1)Show SMILES COc1ncc(cc1C)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOCC3)cc12 |r| Show InChI InChI=1S/C25H31N3O5/c1-17-13-19(15-26-24(17)30-2)28-9-12-32-23-4-3-20(14-22(23)28)33-21-5-8-27(16-21)25(29)18-6-10-31-11-7-18/h3-4,13-15,18,21H,5-12,16H2,1-2H3/t21-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |